Annual Drug Patent Expirations for EPINEPHRINE Epinephrine is a drug marketed by Armstrong Pharms, Belcher, Intl Medication Sys, Am Regent, Hospira, and Teva Pharms Usa and, and is included in…
The post New patent for Belcher drug EPINEPHRINE appeared …
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Denmark? Read Post »
Annual Drug Patent Expirations for BLUDIGO Bludigo is a drug marketed by Provepharm Sas and is included in one NDA. There is one patent protecting this drug. This drug has…
The post New patent for Provepharm Sas drug BLUDIGO appeared first on DrugPaten…
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatc…
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. There are three patents protecting this drug. This drug has one…
The post New patent for MIRUM drug LIVMARLI appeared first on DrugPatentWatch …
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Finland? Read Post »
Get new actionable insights and updates from BiotechBlog
